Latest updates for Emerging Therapy

Fresh curated links around Emerging Therapy are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Where Next For Present Stem Cell Therapies?
  • ai3Bio, built from two biotechs, pursues a different path to an ‘immune reset’
  • <![CDATA[ESC 2026: GLP-1–Based Therapies Move Further into Mainstream Cardiovascular Care]]>

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

fightaging.org /3 weeks ago

Where Next For Present Stem Cell Therapies?

First generation stem cell therapies have become widespread; they are readily accessed in medical tourism clinics, and are also available for a range of issues in more regulated pa...

Read source
biopharmadive.com /3 weeks ago

ai3Bio, built from two biotechs, pursues a different path to an ‘immune reset’

Rather than deplete malfunctioning B cells as many other emerging autoimmune drugs do, Ai3Bio’s therapies are designed to eliminate a particular group of T helper cells.

Read source
pharmexec.com /2 weeks ago

&lt;![CDATA[ESC 2026: GLP-1–Based Therapies Move Further into Mainstream Cardiovascular Care]]&gt;

Read source
pharmexec.com /1 month ago

&lt;![CDATA[How New Therapies are Tackling Unmet Needs in IBS]]&gt;

Read source
edtimes.in /1 month ago

Advanced Therapies Bring New Hope to Blood Cancer Patients in India

Mumbai (Maharashtra) [India], September 2: A blood cancer diagnosis is abrupt and overwhelming. When families hear terms like Acute Myeloid Leukemia or Hodgkin Lymphoma, finding ge...

Read source
biopharmadive.com /3 weeks ago

An ‘off-the-shelf’ CAR-T therapy from Adicet shows promise against lupus

Data from an early trial showed the company’s “gamma delta” cell therapy surpassed benchmarks set by personalized CAR-T treatments tested in lupus.

Read source
timesofindia.indiatimes.com /2 weeks ago

Stanford blood cancer transplant therapy reaches first commercial patient

In a remarkable advancement, Stanford researchers have unveiled Orca-T therapy, which has recently received FDA approval. After two decades of rigorous development, this innovative...

Read source
multiplesclerosisnewstoday.com /2 weeks ago

New therapy moves closer to Phase 2 testing in progressive MS

Quantum Biopharma is collaborating with Thermo Fisher Scientific to prepare a Phase 2 clinical trial of Lucid-MS, an experimental oral therapy designed to slow myelin loss, in peop...

Read source
kevinmd.com /1 month ago

Regulatory T cell reprogramming heads to trial in 2026

Most people have heard of cancer immunotherapy by now. These treatments help a patient’s own immune system recognize and attack cancer. The best-known examples are immune checkpoin...

Read source
orthospinenews.com /1 day ago

ReGen Medical’s Focused Energy Wave Technology Sets New Benchmark in Shockwave Therapy Precision

RCT’s focused-energy approach delivers therapeutic results in 3-5 sessions, now available at the Center for New Medicine in…

Read source
medcitynews.com /1 month ago

First-in-Class Takeda, Protagonist Drug Lands FDA Approval in Rare Blood Disorder

Takeda Pharmaceutical’s Mimrylo is now approved for treating polycythemia vera, a rare blood cancer with limited therapeutic options. Originally developed by Protagonist Therapeuti...

Read source
genengnews.com /1 week ago

Cell Therapy Manufacturing Takes Shape Across Asia-Pacific

Cell and gene therapy is accelerating across Asia-Pacific, but manufacturing remains fragmented. Strategic automation, adaptable bioprocessing platforms, stronger supply chains, an...

Read source
newswire.com /1 month ago

Aptevo Advances Next-Generation Trispecific Candidate Toward Clinical Development

Company Making Critical Progress in Scalable Manufacturing and Preparing the Lead Trispecific Candidate for Future Human TestingTrispecifics Combine Three Complementary Cancer-Figh...

Read source
edtimes.in /1 week ago

First-Line Immunotherapy for Cancer: How the Treatment Order Is Changing in India

Mumbai (Maharashtra) [India], October 12: For much of the past two decades, immunotherapy was thought of as a treatment held in reserve — an option to try after chemotherapy and ra...

Read source
biopharmadive.com /1 month ago

Roivant surges on ‘exceptional’ results; Bristol Myers touts first-of-its-kind CAR-T therapy

One analyst views Roivant’s pulmonary hypertension drug as a future $10 billion-plus seller. Elsewhere, AstraZeneca overcame a negative advisory committee vote and Pharvaris claime...

Read source
medcitynews.com /1 month ago

Electra’s Upsized IPO Lands $350M for New Class of Precision Immunology Drugs

Electra Therapeutics’ IPO cash will support a potential first-in-class drug whose lead indication is a rare hyperinflammatory disorder with no FDA-approved treatments. Meanwhile, c...

Read source
thoughtsonlifeandlove.com /3 weeks ago

How Exosome Therapy Works and Its Emerging Role in Modern Skin Rejuvenation

The world of skin rejuvenation has changed dramatically in just the last few […]

Read source
labiotech.eu /4 weeks ago

New Graft-versus-Host Disease treatments: What’s in the biotech pipeline in 2026?

Over the past decade, a succession of new GvHD treatments targeting different components of the immune response have been approved. The post New Graft-versus-Host Disease treatment...

Read source
fightaging.org /1 month ago

Grip Strength as Biomarker of Aging in the Context of Presently Available Gene Therapies

A range of gene therapies are presently available in the medical tourism community of clinics outside the US and Europe, largely originating with a small number of companies such a...

Read source
labiotech.eu /1 month ago

How AOCs are advancing targeted therapeutics

The concept of targeted therapeutics is often traced back to German Nobel laureate Paul Ehrlich’s “magic bullet” in 1907, which envisioned a single entity that could both recognize...

Read source
fightaging.org /2 weeks ago

KHL Foundation Reports the Likely First Human Partial Epigenetic Reprogramming Treatments

The first human application of partial epigenetic reprogramming of aged tissues, using adeno-associated viral (AAV) vectors, was not in fact the first patient dosed in the recently...

Read source
hemophilianewstoday.com /1 month ago

Flexible injection therapy gets EMA panel nod for hemophilia A

A branch of the European Medicines Agency (EMA) has recommended that the experimental therapy denecimig be approved to treat adults and children with hemophilia A, with or without...

Read source
biopharmadive.com /4 days ago

Hype vs. reality: What pharma’s hottest R&amp;D bets have actually proved

New types of bispecifics, antibody-drug conjugates and cell therapies haven’t yet proven themselves in the clinic. Pharmaceutical companies are betting billions anyway.

Read source
genengnews.com /1 week ago

Designing the Ecosystem for CGT Success

This proceedings eBook, developed in partnership with GEN and Cincinnati Children’s Hospital Applied Gene and Cell Therapy Center, captures perspectives and lessons from The Cell S...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Emerging Therapy

edtimes.in

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

hemophilianewstoday.com

Recent coverage from public sources
Public source

medcitynews.com

Recent coverage from public sources
Public source

multiplesclerosisnewstoday.com

Recent coverage from public sources
Public source